Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Rapid Symptom Reduction Following Intramuscular Ketamine in Refractory Obsessive-Compulsive Disorder: A Case Report.

Angel MiD

Case reports in psychiatryAug 14, 2026License: open accessUnited States0 citationsDOI: 10.1155/crps/6450306

Abstract

<h4>Introduction</h4>Obsessive-compulsive disorder (OCD) is a chronic psychiatric condition that frequently presents with comorbid depressive disorders. For patients exhibiting treatment-refractory OCD and concurrent depressive disorder(s), there is growing clinical interest in the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist ketamine as a rapid-acting intervention. This case report describes a 27-year-old female patient with severe, treatment-refractory OCD and comorbid depressive symptoms, detailing her response to a single intramuscular (IM) ketamine administration.<h4>Case presentation</h4>The patient's primary compulsion was that of handwashing, which she would partake in for ~6 h per handwashing session at the time of the first ketamine administration. This occurred daily over a 3.5-month period, wherein a single day would consist of up to 18 total hours of handwashing. These extreme compulsions resulted in severe in-home isolation, precluding in-person psychotherapy and employment. Despite ongoing management by an independent telepsychiatrist, the patient reported no symptom relief from her prescribed regimen of fluoxetine (80 mg) and alprazolam (1 mg, four times daily)-a pharmacotherapeutic approach that may have been clinically suboptimal given the potential for high-dose benzodiazepines to exacerbate obsessive-compulsive symptoms. Given the severity of her condition, she subsequently pursued treatment at an unaffiliated outpatient ketamine clinic.<h4>Conclusion</h4>Following a single IM ketamine administration, the patient experienced an acute, ~97% reduction in handwashing duration (from 6 h sessions to 5-10 min sessions) sustained over a 10-day period. This observation highlights an acute change in the patient's primary compulsive behavior. However, concurrent pharmacotherapy may confound the results, and prospective controlled trials are required to fully evaluate the efficacy of this intervention.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepressionOCD

Keywords

Case ReportTreatment-refractoryIntramuscularObsessive–compulsive Disorder

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.